Pharmaceutical
Indications

 

43 Results were found on Technologies

Leading Researchers:
5-2011-249

METHODS AND KITS FOR DETERMINING PREDISPOSITION TO DEVELOP KIDNEY DISEASES

Many rare kidney disorders exhibit a monogenic, Mendelian pattern of inheritance. Population-based genetic studies have identified many genetic variants associated with an increased risk of developing common kidney diseases. Strongly associated... Read More >

Leading Researchers:
5-2007-42

Non-invasive Diagnostics for Liver Diseases

The Technology The human asialoglycoprotein receptor (ASGPR) is expressed on the sinusoidal membrane of hepatocytes and serves in the clearance of asialoglycoproteins from the plasma. A soluble form of the ASGPR, termed sH2a, is formed by... Read More >

Leading Researchers:
10-2007-103

Improved Calcitonin-based Therapeutics

TechnologyThe aggregation site on human calcitonin has been identified, paving the way for development of specific inhibitors of calcitonin amyloid fibril formation. Such inhibitors will enable development of improved calcitonin therapeutics as... Read More >

Leading Researchers:
2-2011-142

IAPP Oligomers as a Target for Type 2 Diabetes Novel Immunotherapy

TechnologyStabilized human IAPP (hIAPP) oligomers were used for the development of active immunization of type 2 diabetes. This promising novel approach for the treatment of type 2 diabetes is doable due to the establishment of a new protocol for... Read More >

Leading Researchers:
5-2011-178

Quantitative confluency measurement of culture growth

The invention is an image processing method of light microscopy images for the purpose of quantifying density of cells in cultures . A grayscale image of a cell culture is digitally captured using a light microscope and a CCD camera... Read More >

Leading Researchers:
5-2011-244

Procollagen C-Proteinase Enhancer 1 (PCPE-1) as a Biomarker for Fibrosis relating to the diagnosis of fibrotic diseases based on total PCPE in serum

Collaboration with Dr Shlomit Mesilaty, Dr Yair Anikster, Prof Ido Wolf Metabolic Enzymatic Laboratory, Sheba Medical Center. Bone metastasis is a major clinical concern that can cause severe pain, bone fractures, spinal cord... Read More >

2-2019-1277

An Effective Sema3A Antibody as a Therapy for Optic Nerve Neurodegenerative Diseases

Glaucoma and ischemic or neuro-degenerative diseases of the optic nerve lead to vision loss and blindness. These pathologies are associated with progressive apoptosis of the retinal ganglion cells (RGC), a process which involves expression of... Read More >

Leading Researchers:
2-2011-6

Reviving Matrix for Reconstitution of Severe Peripheral Nerve and Spinal Cord Injuries

Peripheral nerve and spinal cord injuries are debilitating conditions. Annually, the number of peripheral nerve incidences is 13.9 per 100,000 people and nearly 500,000 people worldwide suffer from spinal cord injury (SCI). Consequently, the... Read More >

2-2020-1408

Development of an effective dietary supplement to prevent and treat coronavirus and other viral infections

While most groups are working on the development of drugs and vaccines for SARS-CoV-2, we aim at finding a short-term solution to be ready for use ASAP. Here, we propose a healthy dietary supplement (a combination of several dietary supplements)... Read More >

Leading Researchers:
10-2018-1153

An Oncolytic Virus for Prostate Cancer

An oncolytic virus for melanoma tumors with defective interferon signaling, designed as a potent, specific and safe therapy. Promising in-vivo murine melanoma model shows potential for development as a mono or an add-on to chemotherapy or... Read More >